Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

3.120

+0.090 (2.97%)

At close: Jan 29, 2026, 4:00 PM EST

3.100

-0.020 (-0.64%)

After-hours: Jan 29, 2026, 4:00 PM EST

Anixa Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	2016 - 2020
Net Income	-10.93	-12.55	-9.81	-13.6	-12.95	Upgrade
Depreciation & Amortization	0.04	0.04	0.05	0.04	0.06	Upgrade
Loss (Gain) From Sale of Assets	-	-	-	-	-0.01	Upgrade
Loss (Gain) From Sale of Investments	-0.14	-	-	-	-	Upgrade
Stock-Based Compensation	3.81	4.8	4.74	6.75	8.06	Upgrade
Other Operating Activities	-0.1	-0.14	-0.12	-0.18	-0.17	Upgrade
Change in Accounts Receivable	0.17	0.1	-0.22	-0.03	-	Upgrade
Change in Accounts Payable	-0.36	0.32	-0.06	0.13	-0.1	Upgrade
Change in Other Net Operating Assets	0.34	0.11	-0.78	0.39	0.17	Upgrade
Operating Cash Flow	-7.17	-7.34	-6.21	-6.49	-4.94	Upgrade
Sale of Property, Plant & Equipment	-	-	-	-	0.04	Upgrade
Investment in Securities	4.87	4.28	-5.6	-10.73	-3.96	Upgrade
Investing Cash Flow	4.87	4.28	-5.6	-10.73	-3.92	Upgrade
Issuance of Common Stock	2.39	3.42	0.37	0.45	31.57	Upgrade
Repurchase of Common Stock	-	-0.01	-	-	-	Upgrade
Other Financing Activities	-0.11	-	-	-	-	Upgrade
Financing Cash Flow	2.28	3.42	0.37	0.45	31.57	Upgrade
Net Cash Flow	-0.03	0.36	-11.45	-16.77	22.71	Upgrade
Free Cash Flow	-7.17	-7.34	-6.21	-6.49	-4.94	Upgrade
Free Cash Flow Margin	-	-	-2956.67%	-	-964.45%	Upgrade
Free Cash Flow Per Share	-0.22	-0.23	-0.20	-0.21	-0.17	Upgrade
Levered Free Cash Flow	-3.29	-3	-3.02	-1.26	0.04	Upgrade
Unlevered Free Cash Flow	-3.29	-3	-3.02	-1.26	0.04	Upgrade
Change in Working Capital	0.15	0.53	-1.06	0.49	0.08	Upgrade

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q